摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,3R,4S)-2-({[(1R)-2-hydroxy-1-(4-methoxyphenyl)ethyl]amino}methyl)pyrrolidine-3,4-diol | 1159576-45-0

中文名称
——
中文别名
——
英文名称
(2R,3R,4S)-2-({[(1R)-2-hydroxy-1-(4-methoxyphenyl)ethyl]amino}methyl)pyrrolidine-3,4-diol
英文别名
(2R,3R,4S)-2{{[(1R)-2-hydoxy-1-(4-methoxyphenyl)ethyl]amino}methyl}pyrrolidine-3,4-diol;(2R,3R,4S)-2-[[[(1R)-2-hydroxy-1-(4-methoxyphenyl)ethyl]amino]methyl]pyrrolidine-3,4-diol
(2R,3R,4S)-2-({[(1R)-2-hydroxy-1-(4-methoxyphenyl)ethyl]amino}methyl)pyrrolidine-3,4-diol化学式
CAS
1159576-45-0
化学式
C14H22N2O4
mdl
——
分子量
282.34
InChiKey
OWKCCHVZRKOMOP-ZOBORPQBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.7
  • 重原子数:
    20
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    94
  • 氢给体数:
    5
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    tert-butyl (3aR,4R,6aS)-4-({[(1R)-2-hydroxy-1-(4-methoxyphenyl)ethyl]amino}methyl)-2,2-dimethyltetrahydro-5H-[1,3]dioxolo[4,5-c]pyrrole-5-carboxylate 在 三氟乙酸 作用下, 以 为溶剂, 反应 3.0h, 以76%的产率得到(2R,3R,4S)-2-({[(1R)-2-hydroxy-1-(4-methoxyphenyl)ethyl]amino}methyl)pyrrolidine-3,4-diol
    参考文献:
    名称:
    Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as α-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies
    摘要:
    Novel alpha-mannosidase inhibitors of the type (2R,3R,4S)-2-({[(1R)-2- hydroxy-1-arylethyl]amine}methyl) pyrrolidine-3,4-diol have been prepared and assayed for their anticancer activities. Compound 30 with the aryl group = 4-trifluoromethylbiphenyl inhibits the proliferation of primary cells and cell lines of different origins, irrespective of Bcl-2 expression levels, inducing a G2/Mcell cycle arrest and by modification of genes involved in cell cycle progression and survival. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2010.03.009
点击查看最新优质反应信息

文献信息

  • Derivatives of Dihydroxypyrrolidine as Anti-Cancer Compounds
    申请人:EPFL Ecole Polytechnique Fédérale de Lausanne
    公开号:EP2067771A1
    公开(公告)日:2009-06-10
    The present invention relates to derivatives of dihydroxypyrrolidine useful in the treatment of cancer. The invention further relates to a process for making the compounds. The compounds are inhibitors of α mannosidase, and possibly, also inhibit nicotinamide phosphoribosyl transferase.
    本发明涉及一种二羟基吡咯烷衍生物,可用于癌症治疗。该发明还涉及一种制备该化合物的方法。该化合物是α甘露糖苷酶的抑制剂,可能也抑制烟酰胺磷酸核糖转移酶。
  • Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as α-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies
    作者:Claudia Bello、Michele Cea、Giovanna Dal Bello、Anna Garuti、Ilaria Rocco、Gabriella Cirmena、Eva Moran、Aimable Nahimana、Michel A. Duchosal、Floriana Fruscione、Paolo Pronzato、Francesco Grossi、Franco Patrone、Alberto Ballestrero、Marc Dupuis、Bernard Sordat、Alessio Nencioni、Pierre Vogel
    DOI:10.1016/j.bmc.2010.03.009
    日期:2010.5
    Novel alpha-mannosidase inhibitors of the type (2R,3R,4S)-2-([(1R)-2- hydroxy-1-arylethyl]amine}methyl) pyrrolidine-3,4-diol have been prepared and assayed for their anticancer activities. Compound 30 with the aryl group = 4-trifluoromethylbiphenyl inhibits the proliferation of primary cells and cell lines of different origins, irrespective of Bcl-2 expression levels, inducing a G2/Mcell cycle arrest and by modification of genes involved in cell cycle progression and survival. (C) 2010 Elsevier Ltd. All rights reserved.
查看更多